Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

Recent Press Coverage

  1. The World Health Organization granted prequalification to the novel oral polio vaccine type 2 (nOPV2), an innovative vaccine developed by a consortium of experts including PATH.
    Published: January 2024
  2. PATH has again been named to Forbes’ annual list of the largest charities in the United States, based solely on private contributions. PATH scored 99 percent in fundraising efficiency and 89 percent in charitable commitment.
    Published: December 2023
  3. PATH President and CEO Nikolaj Gilbert outlines the four global health paradigm shifts that are needed to achieve universal health coverage.
    Published: November 2023
  4. Writing in The Lancet, PATH's Dykki Settle, Henry Mwanyika, and co-authors identify three investment areas that could transform primary health care.
    Published: November 2023

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

989 Item s
989 Item s
    Date
    From
    To
  1. At the 14th International Conference on Health and Hepatitis in Substance Users, PATH will highlight our work introducing innovative Hepatitis C virus prevention products and approaches, as well as roadmaps for advancing essential harm reduction services globally.
    Published: September 2026
    Press Release
  2. The Global Fund to Fight AIDS, Tuberculosis, and Malaria selects PATH to landscape, assess, and support antimalarial therapeutic efficacy studies across Sub-Saharan Africa.
    Published: September 2026
    Announcement
  3. The Global Fund to Fight AIDS, Tuberculosis and Malaria selects PATH to lead the Sustainable and Integrated Data Systems grant to support integration efforts in Zambia, Senegal, and Ghana.
    Published: September 2026
    Announcement
  4. Published: September 2026
    Press Release
  5. Targeted antibodies can speed the development and testing of vaccines globally.
    Published: September 2026
    Press Release